AGP Executive Report

ICU Risk in Denmark: A new review links frailty and dependence before ICU admission to higher all-cause mortality, though results vary widely and certainty is very low. Hospital Referrals Under Strain: Denmark rejected about 200,000 referred patients last year—around one in seven—raising concerns that delays and missed diagnoses are worsening, especially for psychiatry, neurology and internal medicine referrals. Obesity Drug Persistence: A Danish cohort study finds nearly half of people stop semaglutide within 12 months, with discontinuation climbing steadily over the year—highlighting a major adherence challenge. Diabetes Safety With SGLT2s: A large registry study across Sweden, Denmark and Norway reports ketoacidosis risk stays elevated throughout treatment, especially with prior ketoacidosis, high glucose, low body weight or malnutrition. Fertility Policy Change: Denmark will set a public-system age limit of 55 for men starting fertility treatment, with courses stopped at 56; private care remains available. Mental Health Access for International Residents: A report says mental health care can be hard to access for internationals in Denmark due to language, cost and referral pathway hurdles. Novo Nordisk Tablet Wegovy in Germany: Wegovy semaglutide tablets become available in German pharmacies from 1 September, as an oral alternative to injections. Company Leadership in Obesity R&D: Resalis Therapeutics appoints Danish cardiothoracic surgeon Diana M. Røpcke as Chief Medical Officer to advance its weight-loss program.

Fertility Policy: Denmark is setting a new public-health age limit: men must start fertility treatment before 55, with all public courses stopped when they turn 56, citing higher risks tied to father’s age; private care remains available. Diabetes Outlook: A Danish-led study projects type 1 diabetes cases worldwide to rise nearly 30% by 2049, with the biggest relative growth expected in low-income countries as access to insulin and monitoring improves. Mental Health Debate: A Danish doctor is reigniting controversy in the UK over “over-diagnosing” depression and anxiety, after new analysis shows women report diagnoses at nearly twice the rate of men. Fraud in Research Funding: A Danish autism researcher, Poul Thorsen, pleaded guilty in the US to stealing $1M+ from CDC grants meant for autism and childhood development research. Cardiology Care: New DISCO trial results at ESC 2026 suggest immediate coronary angiography after out-of-hospital cardiac arrest (without ECG ST-elevation) doesn’t improve 30-day survival versus a deferred approach. Health Data Pilot: A WEF-backed project in Kenya is testing whether people can earn healthcare “rewards points” by sharing medical data for research under privacy-preserving governance. Medical Tech: GE HealthCare received CE mark for its photon-counting CT device, Photonova Spectra, paving the way for European rollout.

GLP-1 Competition: Novo Nordisk launched its Wegovy weight-loss pill in Germany, stepping into a fast-growing oral GLP-1 market as investors watch intensifying rivalry with Eli Lilly. Cardiology Update: The POET-II trial suggests infective endocarditis patients may safely shorten antibiotic courses by about two weeks when treatment is matched to stabilization, though relapse was higher in the shorter group. Stroke Prevention Surgery: The LAACS-2 trial found routine left atrial appendage closure during open-heart surgery doesn’t help all patients, but may benefit those at high stroke risk. Emergency Care in Denmark: The HeartRunner trial reported community first responders did not improve 30-day survival after out-of-hospital cardiac arrest in the Capital Region of Denmark. Denmark Health Policy Spotlight: Two reports on Greenland’s forced contraception program diverge on whether it meets the UN genocide definition, keeping the issue at the center of Denmark-Greenland scrutiny. Wellness & Public Health: A new study from the University of Copenhagen and NASA explores gut changes in astronauts that could also inform constipation care for bedridden patients on Earth.

Cardiology Trial Update: The POET-II study suggests patients with infective endocarditis who stabilize after 2–4 weeks may safely shorten total antibiotics by about a third (41 to 26 days), but with a higher relapse rate in the shorter group. Heart Surgery Guidance: The LAACS-2 trial finds routine left atrial appendage closure during open-heart surgery doesn’t help everyone, though high-stroke-risk patients may benefit. Emergency Care: Denmark’s HeartRunner trial reports community first responders did not improve 30-day survival after out-of-hospital cardiac arrest. Dementia Prevention: A large UK study links early statin use in people with type 2 diabetes to a lower dementia risk (up to ~15%), reinforcing midlife cholesterol control. Denmark-Greenland Rights: Two Greenland reports on Denmark’s decades-long forced contraception reach different conclusions on whether it meets the UN genocide definition, keeping the debate politically and ethically live. Digital Youth Health: Estonia is setting up expert work to reduce harms from social media and gaming on young people’s mental health. Health Tech & Research: GE HealthCare wins CE Mark for Photonova Spectra photon-counting CT, while a UCSF-led network secures $9m to study immune-driven myocarditis and improve targeted treatments.

Rare disease pharma deal: Ascendis Pharma (Denmark) and BioMarin have signed a binding term sheet for a global settlement and license tied to YUVIWEL (navepegritide), with BioMarin granting Ascendis a non-exclusive worldwide royalty-bearing license and both sides dismissing disputes. Dementia prevention angle: A large Danish study presented at ESC Congress 2026 reports that starting statins soon after a type 2 diabetes diagnosis was linked to a lower dementia risk over 10 years (about 15% lower relative risk for early starters). Heart failure drug results: Denmark-led Met-HeFT trial found metformin did not significantly improve cardiovascular outcomes in heart failure patients with diabetes or at risk of diabetes, while H-HeFT found no significant benefit for hydralazine plus isosorbide dinitrate in a broader heart failure population. Nutrition sustainability: Researchers report engineered spirulina grown to contain biologically active vitamin B12 at levels comparable to beef, aiming to improve reliable B12 supply for people with limited access to animal foods. Healthcare policy scrutiny (Denmark/Greenland): Two competing investigations into Greenland’s forced contraception program released sharply different conclusions on whether it meets the legal definition of genocide, with Greenland rejecting the report that definitively ruled genocide out.

Heart Failure Care in Denmark: A Danish government Digital Post email plus a specialist phone invite sharply increased SGLT2 inhibitor uptake for heart failure patients in the EMAIL-HF trial. Cardiology Trial Update: Hydralazine plus isosorbide dinitrate did not significantly improve outcomes in heart failure in the H-HeFT trial, with high discontinuation rates. Diabetes & Heart Failure: Metformin showed no cardiovascular benefit in Met-HeFT for HFrEF patients with diabetes risk. Brain Health & Statins: A large Danish study presented at ESC found statins lowered dementia risk—up to 15% when started earlier—adding to growing interest in cholesterol drugs for long-term cognitive protection. Prevention Spotlight: New imaging data from Denmark and Spain found silent atherosclerosis in over half of healthy adults, including many young adults, suggesting earlier detection could matter. Nutrition Innovation: Researchers report engineered Spirulina that contains biologically active vitamin B12 at beef-comparable levels, aiming to improve sustainable B12 access. Public Health Tech: A separate Danish-led approach is being tested to simplify heart failure treatment uptake using digital registry strategies. Environment & Health: A long-lost WWI submarine wreck off Denmark is leaking TNT into the North Sea, raising concerns for marine life and seafood food chains.

Maternal Nutrition & Autism: A large Danish-linked study of 80,000 mother-child pairs found children whose mothers followed the healthiest pregnancy diets were 22% less likely to receive an autism diagnosis, with researchers stressing it’s an association, not proof of prevention. Statins & Brain Health: Denmark data presented at ESC 2026 suggests statins may cut dementia risk by up to 15%, with earlier use linked to greater benefit. Heart Failure Drug Check: The Met-HeFT trial found metformin did not significantly improve cardiovascular outcomes in HFrEF patients with diabetes or prediabetes. Silent Heart Disease: The REACT study reported widespread “silent” atherosclerosis from early adulthood, detected far more often than standard risk tools would suggest. Digital Care Uptake: The EMAIL-HF trial showed a registry-based digital approach more than doubled uptake of effective heart failure treatment using SGLT2 inhibitors. Nutrition Innovation: Researchers developed carbon-neutral spirulina producing biologically active vitamin B12 at levels comparable to beef. Greenland Rights: Two expert reports say Greenland’s forced contraception violated women’s rights, but did not meet the legal definition of genocide.

Cardiology Breakthrough: Denmark-led REACT research at ESC 2026 finds silent atherosclerosis is widespread from early adulthood—57.1% of 16,808 symptom-free adults had plaques, with sex-specific growth patterns—suggesting today’s risk tools may miss many people who could benefit from earlier prevention. Heart Failure Implementation: The EMAIL-HF trial reports a nationwide digital registry approach that more than doubled uptake of effective SGLT2 inhibitor treatment for untreated heart failure patients via telephone follow-up. Diabetes & Cardiovascular Risk: The US FDA expanded Eli Lilly’s Mounjaro (tirzepatide) to reduce heart attack and stroke risk in high-risk adults with type 2 diabetes. Infective Endocarditis Treatment: POET-II shows response-tailored antibiotics can cut left-sided infective endocarditis treatment duration by about one-third (41 to 26 days) without compromising overall safety. Reproductive Rights in Greenland: Greenland says it cannot yet conclude whether Denmark’s forced contraception campaign meets the legal definition of genocide, though expert reports agree women’s rights were violated. Public Health & Migration: Rwanda is in talks with several European countries about becoming transit hubs for rejected migrants, including Denmark, according to Rwanda’s government.

Psychiatry & Drug Safety: A US murder trial is focusing on whether antidepressants and other psychiatric meds prescribed to Lindsay Clancy before she killed her children could have contributed to postpartum psychosis, raising fresh questions about how clinicians monitor severe mental health side effects after childbirth. Cardiovascular Prevention: New ESC research (REACT) reports silent atherosclerosis is already common in young adults, with prevalence rising sharply with age—fueling calls for earlier primary prevention using advanced imaging. Mental Health Innovation: A Copenhagen-led VR therapy approach is helping a schizophrenia patient confront long-running voices, offering a practical new direction for symptom management. Diabetes Outlook (Denmark-led): EASD modelling led by Steno Diabetes Center Odense estimates type 1 diabetes will rise 29% worldwide by 2049, adding 2.7 million people—an urgent planning signal for healthcare systems. Women’s Health & Accountability: Greenland’s forced contraception inquiry continues after expert reports disagreed on whether it meets the legal definition of genocide, while Denmark’s compensation law moves forward. Public Health & Food Safety: UK salmonella outbreaks linked to eggs continue to widen, with hundreds sickened and investigations expanding. Local Health & Regulation: Police in Paphos arrested suspects after raids found large quantities of cannabis and ecstasy, including an assault on officers during the operation.

Cardiology & Antibiotics: The POET-II trial (ESC 2026) reports that a response-tailored antibiotic plan can cut infective endocarditis treatment by about two weeks in left-sided cases, with similar safety and more time alive off antibiotics. Diabetes & Heart Risk: The US FDA has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce heart attack and stroke risk in high-risk adults with type 2 diabetes, adding to the GLP-1 race beyond weight and glucose control. Greenland Health Rights: Two expert reports say Greenland’s forced contraception violated women’s human rights, but they split on whether it meets the UN genocide definition; Greenland plans a truth-and-reconciliation process while Denmark moves toward compensation. Local Denmark/Europe Health Policy: Denmark is among EU-backed condemnations of Israel’s seizure of a UNRWA facility, underscoring continued support for refugee health services. Research & Prevention: A University of Victoria research boost links marine sustainability with prevention-based health work, including a new digital and community health hub.

Public Health: UKHSA has expanded a Salmonella Enteritidis outbreak linked to imported eggs, now tracking three genetically distinct clusters (t5.9411, t0.24068, t5.9765) with at least two deaths and nearly 500 cases reported across multiple European countries, including Denmark—health officials urge people to eat thoroughly cooked eggs when dining out and follow guidance for vulnerable groups. Workplace Health: A French court has recognised breast cancer as an occupational disease for a former flight attendant, citing night shifts and exposure to ionising radiation at high altitudes, potentially setting a precedent for similar claims. Royal Health & Succession: Norway’s King Harald V died at 89 after hospital treatment for a blood condition and a bacterial infection; Crown Prince Haakon succeeds him, while Denmark’s King Frederik orders flags at half-mast. Global Health Security: UN officials pressed the Security Council to act on conflict-driven food insecurity before it turns into famine, highlighting the role of sanctions and humanitarian access. Innovation in Care: Researchers report progress on biohybrid artificial lungs using additive-manufactured TPMS membranes to improve blood flow and oxygen transfer.

Denmark–Greenland Health Justice: Denmark approved tax-free compensation of about €40,000 (300,000 kroner) for roughly 4,500 Greenlandic women who say they were fitted with IUDs without consent during the “spiral scandal,” with an independent inquiry due to publish reports this week. Cardiology Device Update: Abbott’s next-generation Amulet 360 left atrial appendage occlusion device received CE Mark, aiming to reduce stroke risk in non-valvular AFib patients and potentially lessen reliance on long-term blood thinners. Diabetes & Heart Risk: A large Danish study of nearly 80,000 adults found that consistently taking prescribed type 2 diabetes glucose-lowering medication lowers the risk of major cardiovascular events over 10 years. Public Health Warning: UK salmonella cases linked to imported eggs nearly reached 500, with Denmark reporting one case; authorities stress food safety and ongoing investigations across Europe. Antibiotic Resistance: Experts warn antibiotic misuse—like self-medicating, short courses, or not finishing doses—is driving antimicrobial resistance. Wellbeing & Cities: Copenhagen tops the Happy City Index 2026, with multiple Nordic cities ranking highly—good news for quality-of-life and mental health conversations.

Compensation for IUD abuse in Greenland: Denmark has approved payments of about €40,000 each for an estimated 4,500 Greenlandic women whose IUDs were fitted without consent between 1960 and 1991, with expert reports due to follow. Food safety alert: UK salmonella cases linked to imported eggs are nearing 500, with 474 reported and two deaths; Denmark is among other European countries seeing cases, and investigations are also pointing to possible chicken links. Cancer outlook: A new WHO/IARC GLOBOCAN update projects global cancer cases rising 67% by 2050, with annual deaths expected to climb from 9.8m to 17.5m. Mental health and women’s health: A Danish registry study finds women with endometriosis consistently use more antidepressants, anxiolytics and psychiatric services before and after diagnosis. Clinical conflicts scrutiny: The ESC has judged a former ESC president guilty of severe misconduct over ivabradine guideline work tied to lucrative drug-industry contracts. Heat and health: Germany estimates 15,800 heat-related deaths since the start of the year, highlighting the growing health toll of extreme summers. AI in drug discovery: Novo Nordisk and AWS are partnering to speed drug discovery using agentic AI and cloud tools.

Shingles Vaccine Link to Heart Benefits: A large study using U.S. health records reports that the shingles jab (Shingrix) is associated with lower risk of heart disease, heart failure and stroke over seven years, with benefits seen in both men and women. Fibromyalgia Genetics: The biggest genetic study of fibromyalgia finds the condition’s genetic risk looks essentially the same in men and women, despite fibromyalgia being far more common in women—pointing to non-genetic factors behind the diagnosis gap. Colorectal Cancer Risk Map: Researchers produced the first global, population-based analysis of lifetime colorectal cancer risk across 185 countries, highlighting big differences tied to development, diet shifts and screening access. Social Media Age Rules: Australia’s child social-media ban is now being followed by New Zealand, with a bill proposing a minimum age of 16 for platforms and AI companions deemed harmful. Meta Settlement: Meta agreed to pay billions and change Facebook/Instagram features after U.S. states alleged the platforms were designed to keep children hooked. Denmark Health Policy Watch: Denmark residents are pushing for tighter oversight of Poland Spring’s water extraction permit, citing concerns about local water supplies. Vaccine Researcher in Court: Danish autism-vaccine researcher Poul Thorsen is expected to plead guilty in a U.S. federal fraud case involving CDC grant money. Nordic Skincare Rollout: Kao’s Curél dry-skin brand is expanding across Sweden, Norway, Denmark and Finland from September 2026.

Shingles Vaccines & Heart Protection: New Oxford research in Nature Medicine suggests the NHS shingles jab (Shingrix) could cut risks of heart attacks, stroke and heart failure, with tens of thousands of deaths potentially prevented—while uptake is only about 50% among those eligible. Rectal Cancer Care: The STAR-TREC trial reports long-course chemoradiotherapy beats short-course radiotherapy for organ preservation in early/intermediate rectal cancer, offering hope for avoiding major surgery and a permanent colostomy bag. AI in Diabetes Eye Screening: A Danish study finds AI-assisted diabetic retinopathy screening in primary care can rule out disease well, but also flags substantial false positives—important for how Denmark could roll out AI support safely. Heat & Public Health: Europe’s 2026 heatwaves may have driven at least 35,000 excess deaths, with preliminary figures already topping 25,000 across Germany, France and Spain. Maternal Health Progress: Queen Mary backed the “10 Million Safer Births” initiative, reporting fresh progress to reduce maternal mortality and improve midwife support in sub-Saharan Africa. Fertility Tourism: Americans increasingly travel to Europe for IVF as costs and uncertainty rise at home, with Greece, Spain and the Czech Republic highlighted as lower-cost options.

Cancer Outlook: GLOBOCAN projects cancer cases will rise 67% to 34 million annually by 2050, with deaths also climbing sharply—an urgent signal for prevention and capacity planning. Heat & Public Health: Europe’s back-to-back heatwaves have already driven at least 35,000 excess deaths, with Germany, France and Spain hit hardest—another reminder that climate is now a health emergency. Denmark in the Spotlight: Denmark’s PM Mette Frederiksen faced fresh scrutiny over her appearance after receiving unsolicited comments from a male plastic surgeon, highlighting how women in public life are policed beyond policy. Vaccines & Autism Debate: A new U.S. executive-order push to split MMR is being challenged by experts, who reiterate that large studies find no link between vaccines and autism. Rare Disease / Pharma: Ascendis Pharma will present Week 104 oral trial data on once-weekly TransCon CNP (navepegritide) for children with achondroplasia at ISDS 2026. Cancer Care Innovation: STAR-TREC results suggest many early rectal cancer patients may avoid major surgery and permanent stomas after chemoradiotherapy, with Denmark among participating trial countries. Denmark-linked Business: Novo Nordisk and Eli Lilly remain in the obesity race, with Lilly’s oral obesity launch in the U.K. adding pressure to Denmark’s GLP-1 leader. Healthcare Workforce: Unison reports strike action at four Greater Manchester hospitals over pay and staffing shortages, spotlighting burnout risks in care settings. Policy & Data: The EU’s e-Evidence rules are now landing for covered providers, with enforcement and transposition timelines set to shape cross-border health and legal data handling.